Camc Health System
Clinical trials sponsored by Camc Health System, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a common cholesterol drug help slow liver failure? Results expected Mar 2027 (estimated)
- Radiologists take the lead: can deep sedation replace general anesthesia? Results expected Apr 2027 (estimated)
-
Can adding a second steroid improve survival in severe sepsis?
Disease control CancelledThis trial compares two treatments for people with severe sepsis who also have adrenal insufficiency, a condition where the adrenal glands do not make enough cortisol. Researchers test whether giving fludrocortisone along with hydrocortisone works better than hydrocortisone alone…
Phase 4 • Sponsor: CAMC Health System • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Ketamine may offer better pain relief during biopsies than standard sedation
Symptom relief OngoingThis study tests whether ketamine, combined with midazolam, can reduce pain better than the usual fentanyl and midazolam combination for patients undergoing biopsies or drainage procedures. About 276 adults will be randomly assigned to one of the two sedation methods. Researchers…
Early phase 1 • Sponsor: CAMC Health System • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Can a blood marker tell fever from infection in stroke?
Knowledge-focused CancelledThis study follows adults hospitalized with hemorrhagic stroke to see how procalcitonin, a blood marker, changes over the first few days. The goal is to determine if procalcitonin can help doctors tell whether a fever is due to a bacterial infection or another cause, potentially …
Sponsor: CAMC Health System • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
Virtual doctor visits tested for vascular care – but study never started
Knowledge-focused CancelledThis study planned to compare virtual clinic visits (using video calls on tablets) with in-person visits for people with vascular diseases. Doctors would classify patients as low, moderate, or high risk for treatment after each visit type. The goal was to see if virtual visits co…
Sponsor: CAMC Health System • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC